NERM
NVS icon

New England Research & Management’s Novartis NVS Stock Holding History

New England Research & Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,595
Closed -$276K – 172
2024
Q2 		$276K Sell
2,595
-100
-4% -$10K 0.13% 152
2024
Q1 		$261K Hold
2,695
– – 0.13% 149
2023
Q4 		$272K Hold
2,695
– – 0.14% 143
2023
Q3 		$275K Buy
+2,695
New +$274K 0.16% 136
2020
Q4 		– Sell
-12,558
Closed -$1.09M – 164
2020
Q3 		$1.09M Sell
12,558
-112
-0.9% -$9.7K 0.79% 41
2020
Q2 		$1.11M Buy
12,670
+1,050
+9% +$90.6K 0.79% 43
2020
Q1 		$958K Buy
+11,620
New +$1.04M 0.82% 39
2019
Q2 		– Sell
-2,935
Closed -$253K – 177
2019
Q1 		$253K Sell
2,935
-112
-4% -$8.99K 0.17% 143
2018
Q4 		$234K Sell
3,047
-55
-2% -$4.28K 0.18% 138
2018
Q3 		$240K Hold
3,102
– – 0.16% 140
2018
Q2 		$210K Sell
3,102
-419
-12% -$28.9K 0.14% 157
2018
Q1 		$255K Sell
3,521
-335
-9% -$25.5K 0.17% 143
2017
Q4 		$290K Sell
3,856
-5,016
-57% -$378K 0.21% 120
2017
Q3 		$683K Sell
8,872
-8,147
-48% -$615K 0.5% 77
2017
Q2 		$1.27M Sell
17,019
-670
-4% -$47.5K 0.94% 31
2017
Q1 		$1.18M Buy
17,689
+6,217
+54% +$414K 0.91% 31
2016
Q4 		$749K Buy
11,472
+642
+6% +$41.6K 0.59% 60
2016
Q3 		$766K Buy
10,830
+642
+6% +$46.8K 0.64% 50
2016
Q2 		$753K Buy
+10,188
New +$704K 0.65% 47

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

New England Research & Management's NVS Position: Q3 2024 in Review

New England Research & Management sold out of Novartis (NVS) in Q3 2024, closing a stake of 2,595 shares — an estimated $276K sold.

New England Research & Management first reported a position in NVS in Q2 2016 and held it in 19 quarters. The position peaked at $1.27M in Q2 2017. 1,311 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

  • New England Research & Management reported no remaining Novartis position as of Q3 2024 after selling out during the quarter.
  • New England Research & Management sold 2,595 Novartis shares in Q3 2024, an estimated $276K.
  • New England Research & Management first reported a position in Novartis in Q2 2016 and held it in 19 quarters.
  • New England Research & Management's Novartis position peaked at $1.27M in Q2 2017.
  • 1,311 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on New England Research & Management's 13F filing for Q3 2024, filed 7 Oct 2024.